220 related articles for article (PubMed ID: 5008555)
21. Plasma insulin disturbances in primary hyperparathyroidism.
Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
[TBL] [Abstract][Full Text] [Related]
22. Letter: Phenytoin and glucose utilization.
Rosenbloom AL
JAMA; 1976 Jan; 235(4):374. PubMed ID: 946076
[No Abstract] [Full Text] [Related]
23. [Modalities of blood insulin response to glucose in man].
Malherbe C
Diabete; 1970; 18(4):262-9. PubMed ID: 5501963
[No Abstract] [Full Text] [Related]
24. Diphenylhydantoin as an antiarrhythmic drug.
Atkinson AJ; Davison R
Annu Rev Med; 1974; 25():99-113. PubMed ID: 4596238
[No Abstract] [Full Text] [Related]
25. Glucose-induced insulin release patterns: effect of starvation.
Fink G; Gutman RA; Cresto JC; Selawry H; Lavine R; Recant L
Diabetologia; 1974 Oct; 10(5):421-5. PubMed ID: 4452429
[No Abstract] [Full Text] [Related]
26. [Plasma insulin responses to oral and venous glucose in various forms of diabetes mellitus].
Mirouze J; Orsetti A; Lapinski H
Acta Diabetol Lat; 1970; 7(1):55-67. PubMed ID: 5493439
[No Abstract] [Full Text] [Related]
27. Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity.
Bagdade JD; Porte D; Brunzell JD; Bierman EL
J Lab Clin Med; 1974 Apr; 83(4):563-9. PubMed ID: 4817780
[No Abstract] [Full Text] [Related]
28. Diphenylhydantoin and early diabetes.
Vaisrub S
JAMA; 1973 Oct; 226(2):191. PubMed ID: 4740915
[No Abstract] [Full Text] [Related]
29. Plasma glucose and insulin responses to oral glucose with chronic diphenylhydantoin therapy.
Cummings NP; Rosenbloom AL; Kohler WC; Wilder BJ
Pediatrics; 1973 Jun; 51(6):1091-3. PubMed ID: 4710447
[No Abstract] [Full Text] [Related]
30. Effect of submaxillary gland extirpation on glucose and insulin tolerance in dogs.
Steinberg T; Passy V; Gwinup G
Diabetes; 1972 Jun; 21(6):722-32. PubMed ID: 5029063
[No Abstract] [Full Text] [Related]
31. Hyperglycemia with relative hypoinsulinemia in diphenylhydantoin toxicity.
Peters BH; Samaan NA
N Engl J Med; 1969 Jul; 281(2):91-2. PubMed ID: 5784786
[No Abstract] [Full Text] [Related]
32. Influence of human growth hormone on insulin secretion.
Rabinowitz D
Isr J Med Sci; 1972 Mar; 8(3):413-9. PubMed ID: 5041256
[No Abstract] [Full Text] [Related]
33. [Glucose and insulin level following oral, intrajejunal and intravenous glucose administration in patients undergoing gastric surgery].
Rodrigo Gómez JM; Goberna Ortíz R; Serra Desfilis MA; Aparisi Quereda L; Guix García J; Parrilla Paricio P; Wassel A; Del Olmo Puchalt JA; Garcia-Conde Gomez FJ
Rev Clin Esp; 1976 Mar; 140(5):435-43. PubMed ID: 935569
[No Abstract] [Full Text] [Related]
34. Inhibition of insulin secretion by diphenylhydantoin in the isolated perfused pancreas.
Levin SR; Booker J; Smith DF; Grodsky GM
J Clin Endocrinol Metab; 1970 Mar; 30(3):400-1. PubMed ID: 4904710
[No Abstract] [Full Text] [Related]
35. Study of glucose tolerance and the dynamic property of insulin secretion. Analysis of intravenous glucose tolerance test with the aid of a control theory.
Kawamori R; Shichiri M; Murata T; Nomura M; Shigeta Y; Abe H
Acta Endocrinol (Copenh); 1979 Feb; 90(2):283-94. PubMed ID: 419917
[TBL] [Abstract][Full Text] [Related]
36. The effect of atropine on the insulin release caused by oral and intravenous glucose in human subjects.
Henderson JR; Jefferys DB; Jones RH; Stanley D
Acta Endocrinol (Copenh); 1976 Dec; 83(4):772-80. PubMed ID: 1036650
[TBL] [Abstract][Full Text] [Related]
37. Interactions between diphenylhydantoin and tolbutamide in mice.
Mennear JH; Gossel TA
Toxicol Appl Pharmacol; 1973 Feb; 24(2):309-16. PubMed ID: 4696312
[No Abstract] [Full Text] [Related]
38. Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes.
Efendić S; Cerasi E; Elander I; Thornqvist C; Fick G; Berglund B; Luft R
Acta Endocrinol Suppl (Copenh); 1979; 224():5-32. PubMed ID: 285561
[No Abstract] [Full Text] [Related]
39. Insulin secretion in Addison's disease: effect of hydrocortisone treatment.
Serrano-Rios M; Hawkins FG; Escobar F; Mato JM; Larrodera L; De Oya M; Rodriguez-Miñon JL
Horm Metab Res; 1974 Jan; 6(1):17-21. PubMed ID: 4819287
[No Abstract] [Full Text] [Related]
40. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition.
Sanderson I; Deitel M
Ann Surg; 1974 Apr; 179(4):387-94. PubMed ID: 4205794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
